Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder

Clinical Neuropharmacology

Volumn 28, Issue 3, 2005, Pages 136-138

  Chen, Chin Kang ^a   Shiah, I Shin ^a,b   Yeh, Chin Bin ^a,b   Mao, Wei Chung ^a   Chang, Chuan Chia ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Bipolar disorder; Clozapine; Rapid cycling; Topiramate; Treatment resistant

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CLOTIAPINE; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; RAPID CYCLING BIPOLAR DISORDER; REMISSION; SIDE EFFECT; SOMATIZATION; WEIGHT GAIN;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 21544446718     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000169731.93065.ef     Document Type: Article

References (13)

1. Calabrese JR, Shelton MD, Rapport DJ, et al. Current research on rapid cycling bipolar disorder and its treatment. J Affect Disord. 2001;67:241-255.
2. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry. 1996;153:759-764.
3. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry. 1999;156:1164-1169.
4. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord. 1998;50:245-251.
5. Vieta E, Torrent C, Garcia-Ribas G, et al. Use of topiramate in treatment-resistant bipolar spectrum disorders. J Clin Psychopharmacol. 2002;22: 431-435.
6. Grunze HC, Normann C, Langosch J, et al. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry. 2001;62:464-468.
7. McElroy SL, Suppes T, Keck PE, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 2000;47:1025-1033.
8. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435.
9. Arnone D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry. 2005;4:5.
10. Vieta E, Goikolea JM, Olivares JM, et al. 1-Year follow-up of patients treated with risperidone and topiramate for a manic episode. J Clin Psychiatry. 2003;64:834-839.
11. Covell NH, Weissman EM, Essock SM. Weight gain with clozapine compared to first generation antipsychotic medications. Schizophr Bull. 2004;30:229-240.
12. Suppes T. Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol. 2002;22:599-609.
13. Henderson DC. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. J Clin Psychiatry. 2001;62(Suppl 23):39-44.